ada.enesco, Author at European Medical Journal - Page 8 of 27

Antibiotic Resistance in Diabetes: New Research Reveals Concerning Trend

A recent study has uncovered a worrying link between diabetes and the rapid emergence of antibiotic resistance.

New Cambridge Study Reveals Vaccine Challenges for Immunocompromised Individuals

The study highlights the necessity of a third vaccination to detect neutralising activity, particularly against emerging Omicron subvariants.

Air Pollution Exposure Linked to Liver Inflammation and Fatty Liver Disease

Even low levels of air pollution can cause liver inflammation, fibrosis, and metabolic changes linked to fatty liver disease.

Salt Substitute Cuts Stroke Risk and Mortality in Major Clinical Trial

Replacing regular salt with a reduced-sodium, added-potassium substitute significantly lowered recurrent stroke and mortality risk in stroke patients.

Avacopan Shows Promise for ANCA-Associated Vasculitis Despite High Discontinuation Rates

A new Japanese retrospective study confirms that avacopan can effectively induce and sustain remission in patients with ANCA-associated vasculitis, reducing the need for glucocorticoids.

Abortion Bans Linked to 5.6% Increase in Infant Mortality in the USA

A new study has found that infant mortality rates have increased in US states that enacted abortion bans, with Black infants, those with congenital anomalies, and those in southern states facing the highest risks.

Faecal Microbiota Transplantation: A New Era for C. difficile Treatment

A new systematic review and network meta-analysis confirms that faecal microbiota transplantation is the most effective treatment for Clostridioides difficile infection.

Personalized IgG-Based Elimination Diet Reduces IBS Symptoms in New Trial

A groundbreaking multicenter clinical trial has found that a personalized elimination diet guided by an IBS-specific IgG antibody assay significantly reduces abdominal pain intensity and symptoms in IBS patients.

New Approach Lowers Pemphigus Relapse Risk with Additional Rituximab

A targeted rituximab infusion at 6 months, based on relapse predictors, significantly reduced pemphigus recurrence at one year.

Camel Milk Shows Promise as a Less Allergenic Dairy Alternative

Fractionation techniques can significantly enhance the identification of bioactive peptides and immune-related proteins in camel and cow milk.